HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Etiological diagnosis of undervirilized male/XY disorder of sex development.

AbstractOBJECTIVE:
To do clinical, hormonal and chromosomal analysis in undervirilized male / XY disorder of sex development and to make presumptive etiological diagnosis according to the new Disorder of Sex Development (DSD) classification system.
STUDY DESIGN:
Case series.
PLACE AND DURATION OF STUDY:
Endocrine Unit at National Institute of Child Health, Karachi, Pakistan, from January 2007 to December 2012.
METHODOLOGY:
Patients of suspected XY DSD / undervirilized male visiting endocrine clinic were enrolled in the study. Criteria suggested XY DSD include overt genital ambiguity, apparent female/male genitalia with inguinal/labial mass, apparent male genitalia with unilateral or bilateral non-palpable testes, micropenis and isolated hypospadias or with undescended testis. The older children who had delayed puberty were also evaluated with respect to DSD. As a part of evaluation of XY DSD, abdominopelvic ultrasound, karyotype, hormone measurement (testosterone, FSH, LH), FISH analysis with SRY probing, genitogram, laparoscopy, gonadal biopsy and HCG stimulation test were performed. Frequencies and percentages applied on categorical data whereas mean, median, standard deviation were calculated for continuous data.
RESULTS:
A total of 187 patients met the criteria of XY DSD. Age ranged from 1 month to 15 years, 55 (29.4%) presented in infancy, 104 (55.6%) between 1 and 10 years and 28 (15%) older than 10 years. Twenty five (13.4%) were raised as female and 162 as (86.6%) male. The main complaints were ambiguous genitalia, unilateral cryptorchidism, bilateral cryptorchidism, micropenis, delayed puberty, hypospadias, female like genitalia with gonads, inguinal mass. The karyotype was 46 XY in 183 (97.9%), 46 XX in 2 (1.1%), 47 XXY in 1 (0.5%), 45 X/46 XY in 1 (0.5%) patient. HCG stimulation test showed low testosterone response in 43 (23 %), high testosterone response in 62 (33.2%), partial testosterone response in 32 (17.1%) and normal testosterone response in 50 (26.7%). Genitogram was carried out in 86 (45.98%) patients. Presumptive etiological diagnosis of androgen sensitivity syndrome/ 5-alpha reductase deficiency, testicular biosynthetic defect/ leydig cell hypoplasia, partial gonadal dysgenesis, ovotesticular DSD, XX testicular DSD, mixed gonadal dysgenesis, testicular vanishing syndrome, klinefelter syndrome, hypogonadotropic hypogonadism, isolated hypospadias and isolated micropenis was made.
CONCLUSION:
Clinical, chromosomal and hormonal assessment may help in making the presumptive etiological diagnosis. Further molecular genetics analysis are needed in differentiating these abnormalities and to make a final diagnosis.
AuthorsIrum Atta, Mohsina Ibrahim, Arit Parkash, Saira Waqar Lone, Yasir Naqi Khan, Jamal Raza
JournalJournal of the College of Physicians and Surgeons--Pakistan : JCPSP (J Coll Physicians Surg Pak) Vol. 24 Issue 10 Pg. 714-8 (Oct 2014) ISSN: 1681-7168 [Electronic] Pakistan
PMID25327912 (Publication Type: Journal Article)
Chemical References
  • Testosterone
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Topics
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase (deficiency)
  • Adolescent
  • Child
  • Child, Preschool
  • Disorder of Sex Development, 46,XY (diagnosis, etiology)
  • Disorders of Sex Development (classification, diagnosis, etiology, genetics)
  • Female
  • Gonadal Dysgenesis, 46,XY (diagnosis, etiology)
  • Humans
  • Hypospadias (diagnosis, etiology)
  • Klinefelter Syndrome (diagnosis, etiology)
  • Male
  • Pakistan
  • Sexual Development (physiology)
  • Steroid Metabolism, Inborn Errors (diagnosis, etiology)
  • Testis (abnormalities)
  • Testosterone

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: